Placebo

Placebo designates an inert substance or sham intervention administered to control groups in clinical trials, appearing identical to the active treatment but containing no therapeutic ingredients. Placebos serve as essential comparators for establishing whether investigational therapies produce effects beyond psychological expectations or natural disease progression, forming the methodological foundation of evidence-based medicine.

Placebo-controlled trials enable researchers to isolate true pharmacological effects from placebo responses, which can produce measurable physiological changes including pain reduction and improved motor function. The magnitude of placebo effects varies across therapeutic areas, with pain management, psychiatric conditions, and gastrointestinal disorders exhibiting particularly robust responses. The biopharmaceutical industry navigates complex ethical and practical considerations surrounding placebo use. While regulators prefer placebo-controlled designs for establishing efficacy, ethical guidelines prohibit placebo comparisons when effective standard therapies exist. Innovative designs including placebo run-ins to identify high placebo responders, active-controlled non-inferiority trials, and enrichment strategies minimise placebo exposure while maintaining scientific rigour. Understanding placebo mechanisms remains a research priority, with neuroimaging studies revealing brain networks mediating expectation effects.